Nav: Home

Patients at a reduced risk of venous thromboembolism and persistent pain after partial versus total knee replacement

June 13, 2019

Annual European Congress of Rheumatology (EULAR 2019)
Madrid, Spain, 12-15 June 2019

Madrid, Spain, 13 June 2019: The results of a study presented today at the Annual European Congress of Rheumatology (EULAR 2019) demonstrate reduced risk of venous thromboembolism and persistent pain, but increased risk of revision in partial versus total knee replacement in patients with osteoarthritis.1

In severe knee osteoarthritis, there are two main types of surgical intervention; partial or total knee replacement. In partial knee replacement only the part of the knee that has osteoarthritis is replaced, whereas in total knee replacement the entire joint is replaced. Although partial knee replacement has been associated with significant advantages, high rates of revision have been reported. This is where the implant components are removed, added or replaced. While partial knee replacement is cheaper than total knee replacement, there is uncertainty as to which surgery is better for patients. This is reflected by variability in the use of partial knee replacement with, for example, 50% of patients eligible for either procedure in the UK but less than 10% receiving a partial knee replacement.

"Our study clearly demonstrates significant short-term advantages of partial knee replacement over total knee replacement and although the long-term risk of revision is higher for partial knee replacement, this is likely, at least partly, explained by a greater willingness to revise a partial knee replacement", said Edward Burn, DPhil student, Centre for Statistics in Medicine, University of Oxford, United Kingdom. "The results of our study based on real-world data will complement those from a forthcoming randomised controlled trial comparing the two procedures, the Total Or Partial Knee Arthroplasty Trial (TOPKAT)".

The study by Mr Burn and colleagues from across Europe and the United States, replicated the design of the TOPKAT trial in real-world data and included 32,379 and 250,377 patients who received partial or total knee replacement respectively. They found partial knee replacement is associated with a 25-50% reduction in the 60-day risk of venous thromboembolism after surgery, and a 15-30% lower risk of persistent pain after surgery. However, partial knee replacement was also associated with an increased risk of revision, with the five-year risk of revision increasing from around 2.5-5% for total knee replacement to 5-7.5% for partial knee replacement.1

"There is a lack of clinical consensus on the profile of patients with osteoarthritis suitable for partial versus total knee replacement," said Professor Hans Bijlsma, President, EULAR. "We welcome these data as they will help inform both patients and physicians to support an individualised approach to care."

This multi-database propensity-score matched cohort study included data from four US claims databases (IBM MarketScan® Commercial Database (CCAE), IBM MarketScan® Medicare Supplemental Database (MDCR), Optum® de-identified Clinformatics Datamart Extended - Date of Death (Optum), and Pharmetrics) and one UK primary care electronic medical record database (THIN). All people aged 40 years or older at the time of first knee replacement surgery were included and followed for up to five years. Outcomes included short-term (60-day) post-operative complications (infection, venous thromboembolism, mortality, readmission), opioid use in the three to 12 months post-surgery as a proxy for persistent pain, and five-year revision risk. Propensity score matching (up to 1:10) was used to control for all available confounders, and negative control outcomes and calibration to minimise the impact of residual confounding.

Abstract number: OP0174
-end-
NOTES TO EDITORS

For further information on this study, or to request an interview with the study lead, please do not hesitate to contact the EULAR Press Office:

Email: eularpressoffice@ruderfinn.co.uk
Telephone: +44 (0) 20 7438 3084
Twitter: @EULAR_Press
YouTube: YouTube.com/EULARorg

About Rheumatic and Musculoskeletal Diseases

Rheumatic and musculoskeletal diseases (RMDs) are a diverse group of diseases that commonly affect the joints, but can affect any organ of the body. There are more than 200 different RMDs, affecting both children and adults. They are usually caused by problems of the immune system, inflammation, infections or gradual deterioration of joints, muscle and bones. Many of these diseases are long term and worsen over time. They are typically painful and Iimit function. In severe cases, RMDs can result in significant disability, having a major impact on both quality of life and life expectancy.

About 'Don't Delay, Connect Today!'

'Don't Delay, Connect Today!' is a EULAR initiative that unites the voices of its three pillars, patient (PARE) organisations, scientific member societies and health professional associations - as well as its international network - with the goal of highlighting the importance of early diagnosis and access to treatment. In the European Union alone, over 120 million people are currently living with a rheumatic disease (RMD), with many cases undetected. The 'Don't Delay, Connect Today!' campaign aims to highlight that early diagnosis of RMDs and access to treatment can prevent further damage, and also reduce the burden on individual life and society as a whole.

About EULAR

The European League against Rheumatism (EULAR) is the European umbrella organisation representing scientific societies, health professional associations and organisations for people with RMDs. EULAR aims to reduce the burden of RMDs on individuals and society and to improve the treatment, prevention and rehabilitation of RMDs. To this end, EULAR fosters excellence in education and research in the field of rheumatology. It promotes the translation of research advances into daily care and fights for the recognition of the needs of people with RMDs by the EU institutions through advocacy action.

To find out more about the activities of EULAR, visit: http://www.eular.org

References
    1. Prieto-Alhambra D, Burn E, Weaver J, et al. Partial knee replacement is associated with a lower risk of venous thromboembolism and opioid use than total knee replacement but increased risk of long-term revision: a multinational, multi-database, propensity score-matched, cohort analysis including over 280,000 patients. EULAR 2019; Madrid: Abstract OP0174.

    2. Oosthuizen CR, Takahashi T, Rogan M, et al. The Knee Osteoarthritis Grading System for Arthroplasty. J Arthroplasty. 2019;34(3):450-455.

    3. Burn E, Liddle AD, Hamilton TW, et al. Choosing Between Unicompartmental and Total Knee Replacement: What Can Economic Evaluations Tell Us? A Systematic Review. Pharmacoecon Open. 2017 Dec;1(4):241-253.

    4. Green M, Wishart N, Young E, et al. National Joint Registry 14th Annual Report. 2017;1821. Available at: http://www.njrcentre.org.uk/njrcentre/Reports-Publications-and-Minutes/Annual-reports. [Last accessed May 2019].

    5. van der Heijde D, Daikh DI, Betteridge N, et al. Common language description of the term rheumatic and musculoskeletal diseases (RMDs) for use in communication with the lay public, healthcare providers and other stakeholders endorsed by the European League Against Rheumatism (EULAR) and the American College of Rheumatology (ACR). Ann Rheum Dis. 2018 Jun;77(6):829-832.

    6. EULAR. 10 things you should know about rheumatic diseases fact sheet. Available at: https://www.eular.org/myUploadData/files/10%20things%20on%20RD.pdf [Last accessed May 2019].

    European League Against Rheumatism

    Related Osteoarthritis Articles:

    App helps reduce osteoarthritis pain
    By performing a few simple physical exercises daily, and receiving information about their disease regularly, 500 osteoarthritis patients were able to on average halve their pain in 6 months -- and improve their physical function.
    Osteoarthritis can increase your risk for social isolation
    In a study published in the Journal of the American Geriatrics Society, researchers examined information from the European Project on OSteoArthritis (EPOSA) study.
    High rates of opioid prescriptions for osteoarthritis
    Opioids work against severe pain but the risks of side effects and addiction are high.
    Disease burden in osteoarthritis is similar to rheumatoid arthritis
    Osteoarthritis (OA) has traditionally been viewed as a highly prevalent but milder condition when compared with rheumatoid arthritis (RA), and some may believe that it is part of a normal aging process requiring acceptance, not treatment.
    3D printing may help treat osteoarthritis
    In a Journal of Orthopaedic Research study, scientists used 3D printing to repair bone in the joints of mini-pigs, an advance that may help to treat osteoarthritis in humans.
    Finger joint enlargements may be linked to knee osteoarthritis
    Heberden's nodes (HNs) are bony enlargements of the finger joints that are readily detectable in a routine physical exam and are considered hallmarks of osteoarthritis.
    Hormone therapy may be best defense against knee osteoarthritis
    There is an ongoing debate regarding the relationship between knee osteoarthritis and hormone therapy (HT), with small-scale studies providing mixed results.
    Going from negative to positive in the treatment of osteoarthritis
    A scientific team has designed a charged molecule that improved the delivery of osteoarthritis drugs to knee joint cartilage in rodent models of the debilitating joint disorder.
    Antioxidant defender protects against osteoarthritis
    A protein involved in multiple cellular processes called ANP32A protects cartilage in the joints against degradation by damaging oxidation, preventing the development and progression of osteoarthritis, according to a new study by Frederique Cornelis and colleagues.
    Symptoms of osteoarthritis lessened with simple changes to the diet
    One gram of fish oil a day could help reduce the pain of patients with osteoarthritis, a new study in Rheumatology reports.

Trending Science News

Current Coronavirus (COVID-19) News

Top Science Podcasts

We have hand picked the top science podcasts of 2020.
Now Playing: TED Radio Hour

Listen Again: Reinvention
Change is hard, but it's also an opportunity to discover and reimagine what you thought you knew. From our economy, to music, to even ourselves–this hour TED speakers explore the power of reinvention. Guests include OK Go lead singer Damian Kulash Jr., former college gymnastics coach Valorie Kondos Field, Stockton Mayor Michael Tubbs, and entrepreneur Nick Hanauer.
Now Playing: Science for the People

#562 Superbug to Bedside
By now we're all good and scared about antibiotic resistance, one of the many things coming to get us all. But there's good news, sort of. News antibiotics are coming out! How do they get tested? What does that kind of a trial look like and how does it happen? Host Bethany Brookeshire talks with Matt McCarthy, author of "Superbugs: The Race to Stop an Epidemic", about the ins and outs of testing a new antibiotic in the hospital.
Now Playing: Radiolab

Dispatch 6: Strange Times
Covid has disrupted the most basic routines of our days and nights. But in the middle of a conversation about how to fight the virus, we find a place impervious to the stalled plans and frenetic demands of the outside world. It's a very different kind of front line, where urgent work means moving slow, and time is marked out in tiny pre-planned steps. Then, on a walk through the woods, we consider how the tempo of our lives affects our minds and discover how the beats of biology shape our bodies. This episode was produced with help from Molly Webster and Tracie Hunte. Support Radiolab today at Radiolab.org/donate.